Literature DB >> 19110031

Cell-specific loss of kappa-opioid receptors in oligodendrocytes of the dysmyelinating jimpy mouse.

Pamela E Knapp1, Valeriya V Adjan, Kurt F Hauser.   

Abstract

Jimpy is a murine mutation in myelin proteolipid protein, leading to premature death of oligodendrocytes and severe central nervous system hypomyelination. Jimpy is a bona fide model of human Pelizaeus-Merzbacher disease. This paper describes a severe reduction in expression of kappa-opioid receptors (KOP) in oligodendrocytes of jimpy mice. A cell-specific reduction of >90% is apparent by 5 days of age. Expression is not reduced in neurons, and mu-opioid receptor expression is normal. Mechanism(s) leading to deficient KOP expression in jimpy mice remain unclear. We speculate that loss of KOP may be related to increased [Ca(2+)](i) and premature death of jimpy oligodendrocytes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19110031      PMCID: PMC4029417          DOI: 10.1016/j.neulet.2008.12.022

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  51 in total

1.  Mu- and delta-opioid receptor antagonists decrease proliferation and increase neurogenesis in cultures of rat adult hippocampal progenitors.

Authors:  Anders I Persson; Thorleif Thorlin; Cecilia Bull; Parisa Zarnegar; Rolf Ekman; Lars Terenius; Peter S Eriksson
Journal:  Eur J Neurosci       Date:  2003-03       Impact factor: 3.386

2.  Myelin deficit in the Jimpy mouse may be due to cellular abnormalities in astroglia.

Authors:  R P Skoff
Journal:  Nature       Date:  1976-12-09       Impact factor: 49.962

3.  Abnormal Ca(2+) regulation in oligodendrocytes from the dysmyelinating jimpy mouse.

Authors:  P E Knapp; S Ismaili; K F Hauser; M S Ghandour
Journal:  Brain Res       Date:  1999-11-20       Impact factor: 3.252

4.  Endogenous opioids and oligodendroglial function: possible autocrine/paracrine effects on cell survival and development.

Authors:  P E Knapp; O S Itkis; L Zhang; B A Spruce; G Bakalkin; K F Hauser
Journal:  Glia       Date:  2001-08       Impact factor: 7.452

5.  Cytotoxic effects of dynorphins through nonopioid intracellular mechanisms.

Authors:  K Tan-No; G Cebers; T Yakovleva; B Hoon Goh; I Gileva; K Reznikov; M Aguilar-Santelises; K F Hauser; L Terenius; G Bakalkin
Journal:  Exp Cell Res       Date:  2001-09-10       Impact factor: 3.905

6.  An immortalized jimpy oligodendrocyte cell line: defects in cell cycle and cAMP pathway.

Authors:  A C Feutz; D Pham-Dinh; B Allinquant; M Miehe; M S Ghandour
Journal:  Glia       Date:  2001-06       Impact factor: 7.452

7.  Opioid system diversity in developing neurons, astroglia, and oligodendroglia in the subventricular zone and striatum: impact on gliogenesis in vivo.

Authors:  A Stiene-Martin; P E Knapp; K Martin; J A Gurwell; S Ryan; S R Thornton; F L Smith; K F Hauser
Journal:  Glia       Date:  2001-10       Impact factor: 7.452

8.  Trafficking of PLP/DM20 and cAMP signaling in immortalized jimpy oligodendrocytes.

Authors:  M Said Ghandour; Anne-Catherine Feutz; Walid Jalabi; Omar Taleb; Denise Bessert; Maria Cypher; Leon Carlock; Robert P Skoff
Journal:  Glia       Date:  2002-12       Impact factor: 7.452

9.  Dynorphin A toxicity in striatal neurons via an alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor mechanism.

Authors:  R J Goody; K M Martin; S M Goebel; K F Hauser
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

Review 10.  G-protein-coupled receptor-signaling components in membrane raft and caveolae microdomains.

Authors:  H H Patel; F Murray; P A Insel
Journal:  Handb Exp Pharmacol       Date:  2008
View more
  6 in total

1.  Enhancing Remyelination through a Novel Opioid-Receptor Pathway.

Authors:  Jeremy C Borniger; Zoe C Hesp
Journal:  J Neurosci       Date:  2016-11-23       Impact factor: 6.167

Review 2.  Opiate drug use and the pathophysiology of neuroAIDS.

Authors:  Kurt F Hauser; Sylvia Fitting; Seth M Dever; Elizabeth M Podhaizer; Pamela E Knapp
Journal:  Curr HIV Res       Date:  2012-07       Impact factor: 1.581

3.  Co-occurrence of preconception maternal childhood adversity and opioid use during pregnancy: Implications for offspring brain development.

Authors:  Madeleine C Allen; Nora K Moog; Claudia Buss; Elizabeth Yen; Hanna C Gustafsson; Elinor L Sullivan; Alice M Graham
Journal:  Neurotoxicol Teratol       Date:  2021-09-30       Impact factor: 4.071

Review 4.  Opiate Drugs with Abuse Liability Hijack the Endogenous Opioid System to Disrupt Neuronal and Glial Maturation in the Central Nervous System.

Authors:  Kurt F Hauser; Pamela E Knapp
Journal:  Front Pediatr       Date:  2018-01-23       Impact factor: 3.418

5.  N-acetylcysteine Provides Cytoprotection in Murine Oligodendrocytes through Heme Oxygenase-1 Activity.

Authors:  Jie Zhou; Marcia R Terluk; Lisa Basso; Usha R Mishra; Paul J Orchard; James C Cloyd; Henning Schröder; Reena V Kartha
Journal:  Biomedicines       Date:  2020-07-23

Review 6.  Opioid and neuroHIV Comorbidity - Current and Future Perspectives.

Authors:  Sylvia Fitting; MaryPeace McRae; Kurt F Hauser
Journal:  J Neuroimmune Pharmacol       Date:  2020-09-02       Impact factor: 4.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.